Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance Thibault

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
European Urology Oncology|August 2, 2025
The Evolving Landscape of Systemic Immunotherapy for Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer: At the Edge of a Tsunami?Pierre-Etienne Gabriel, Mathieu Roumiguié, Gautier Marcq, et al.
Clinical Genitourinary Cancer|December 5, 2025
Impact of FGFR3 Alterations on First-Line Platinum Based Chemotherapy in Patients With Metastatic or Locally Advanced Urothelial Carcinoma: The Retrospective IFUCA StudyThibaut Reverdy, Floriane Izarn, Benoit Allignet, et al.
Bulletin Du Cancer|June 20, 2022
[Locally advanced or metastatic bladder cancer: Identification of barriers and levers of patients' pathway in France]Nadine Houédé, Cécile Flahault, Marine Gross-Goupil, et al.
Annals of Intensive Care|March 8, 2017
Outcomes in elderly patients admitted to the intensive care unit with solid tumorsEdouard Auclin, Anaïs Charles-Nelson, Baptiste Abbar, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Upper urinary tract urothelial cancer (UTUC)Mathieu Roumiguié, Thomas Seisen, Alexandra Masson-Lecomte, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Non-muscle invasive bladder cancer (NMIBC)Mathieu Roumiguié, Priscilla Leon, Evanguelos Xylinas, et al.
Molecular and Cellular Endocrinology|July 1, 2015
From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytomaCharlotte Lepoutre-Lussey, Constance Thibault, Alexandre Buffet, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Muscle-invasive bladder cancer (MIBC)Mathieu Roumiguié, Gautier Marcq, Yann Neuzillet, et al.
Frontiers in Oncology|June 7, 2021
Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective StudyNicolas Epaillard, Pauline Parent, Yohann Loriot, et al.
The French Journal of Urology|October 19, 2025
French recommendations of the AFU Oncology Committee for Bladder Cancer: Update 2025Mathieu Roumiguié, Evanguelos Xylinas, Pierre Etienne Gabriel, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
European Urology Oncology|August 2, 2025
The Evolving Landscape of Systemic Immunotherapy for Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer: At the Edge of a Tsunami?Pierre-Etienne Gabriel, Mathieu Roumiguié, Gautier Marcq, et al.
Clinical Genitourinary Cancer|December 5, 2025
Impact of FGFR3 Alterations on First-Line Platinum Based Chemotherapy in Patients With Metastatic or Locally Advanced Urothelial Carcinoma: The Retrospective IFUCA StudyThibaut Reverdy, Floriane Izarn, Benoit Allignet, et al.
Bulletin Du Cancer|June 20, 2022
[Locally advanced or metastatic bladder cancer: Identification of barriers and levers of patients' pathway in France]Nadine Houédé, Cécile Flahault, Marine Gross-Goupil, et al.
Annals of Intensive Care|March 8, 2017
Outcomes in elderly patients admitted to the intensive care unit with solid tumorsEdouard Auclin, Anaïs Charles-Nelson, Baptiste Abbar, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Upper urinary tract urothelial cancer (UTUC)Mathieu Roumiguié, Thomas Seisen, Alexandra Masson-Lecomte, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Non-muscle invasive bladder cancer (NMIBC)Mathieu Roumiguié, Priscilla Leon, Evanguelos Xylinas, et al.
Molecular and Cellular Endocrinology|July 1, 2015
From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytomaCharlotte Lepoutre-Lussey, Constance Thibault, Alexandre Buffet, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Muscle-invasive bladder cancer (MIBC)Mathieu Roumiguié, Gautier Marcq, Yann Neuzillet, et al.
Frontiers in Oncology|June 7, 2021
Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective StudyNicolas Epaillard, Pauline Parent, Yohann Loriot, et al.
The French Journal of Urology|October 19, 2025
French recommendations of the AFU Oncology Committee for Bladder Cancer: Update 2025Mathieu Roumiguié, Evanguelos Xylinas, Pierre Etienne Gabriel, et al.
Pageof 11